Bob Blouin, PharmD
Executive Vice Chancellor, UNC-Chapel Hill
Dr. Robert A. “Bob” Blouin serves as the provost, Chief Academic Officer and Chief Operating Officer of the university.
|
John Bamforth, PhD
Interim Director, READDI
Director of Eshelman Institute for Innovation at UNC Eshelman School of Pharmacy, UNC-Chapel Hill Dr. John Bamforth oversees efforts to accelerate the creation and development of new medicines and technologies.
|
Angela Kashuba, PharmD
Dean, UNC Eshelman School of Pharmacy, John and Deborah McNeill, Jr. Distinguished Professor
Dr. Angela Kashuba serves as director of the UNC Center for AIDS Research Clinical Pharmacology and Analytical Chemistry Core.
|
Barbara Rimer, DrPH, MPH
Dean and Alumni Distinguished Professor, UNC Gillings School of Global Public Health
Dr. Barbara K. Rimer is the first woman and behavioral scientist to chair the National Cancer Institute's National Cancer Advisory Board.
|
Wesley Burks, MD
Dean, UNC School of Medicine, Chief Executive Officer, UNC Health Care, Vice Chancellor for Medical Affairs
Dr. A. Wesley Burks leads growth efforts in education, research and clinical care through the UNC School of Medicine.
|
Terry Magnuson, PhD
Kay M. & Van L. Weatherspoon Eminent Distinguished Professor, UNC Department of Genetics, UNC Vice Chancellor for Research
Dr. Terry Magnuson is the founding chair of the UNC Department of Genetics. He oversees, develops and supports UNC-Chapel Hill’s $1 billion research enterprise. |
Ralph Baric, PhD
William R. Kenan, Jr. Distinguished Professor, Department of Epidemiology, Department of Microbiology and Immunology, UNC-Chapel Hill
Dr. Ralph S. Baric has spent the past three decades as a world leader in the study of coronaviruses and is responsible for UNC-Chapel Hill’s world leadership in coronavirus research.
|
Ralph Baric, PhD (Chair)
William R. Kenan, Jr. Distinguished Professor, Department of Epidemiology, Department of Microbiology and Immunology, UNC-Chapel Hill
Dr. Ralph S. Baric has spent the past three decades as a world leader in the study of coronaviruses and is responsible for UNC-Chapel Hill’s world leadership in coronavirus research.
|
Nat Moorman, PhD
Associate Professor, UNC School of Microbiology and Immunology
Dr. Nat Moorman’s research includes studying how viruses hijack cellular machinery to facilitate their replication.
|
Mark Heise, PhD
Professor, Department of Genetics at the UNC School of Medicine
Dr. Mark Heise researches how viral and host genetic factors interact to influence the pathogenesis of virus-induced disease.
|
Tim Willson, PhD
Chief Scientist, SGC-UNC
Dr. Tim Willson is chief scientist of the SGC-UNC, an open-discovery network for protein kinases based at the UNC Eshelman School of Pharmacy.
|
READDI is led by The University of North Carolina at Chapel Hill.
|